S., Pistilli, E., Guerron, A
Conducting rigorous studies like those that established the benefits of injectable GLP-1 RAs such as tirzepatide, semaglutide, dulaglutide, and liraglutide on CKD, MASH, and cardiovascular outcomes will be crucial in determining the full clinical utility of these novel agents
Still, the study remains noteworthy as the first RCT of its kind evaluating acupuncture specifically for HT
Rather than positioning GLP-1s as a silver bullet or dismissing them outright this keynote will challenge clinicians to think critically, ethically, and systemically about where these therapies belong in practice
The higher blood concentration from compressed dosing can increase nausea, particularly if you're already experiencing GI side effects or recently escalated dose